Hemoglobin A1c and Fasting Glucose Interpretation in Non-Diabetic Athletes: Why the Paired Panel Catches the Reduced-Carbohydrate-Tolerance Pattern CGM Alone Misses, the Athlete-Specific Functional Thresholds That Shift Below the Standard Non-Diabetic Reference Band, and How the Sports RD Documents the Metabolic-Flexibility Read So the Follow-Up Conversation Starts at the Correct Question

A 38-year-old male masters marathoner arrives on referral from his sports medicine physician with a chief complaint of stalled performance across the last two training cycles despite what his coach's TrainingPeaks record documents as textbook periodization. His post-workout glucose readings on a two-week CGM trial have looked "fine" — no spikes above 160 mg/dL on his carbohydrate-loaded long-run breakfasts, no crashes below 60 mg/dL during his long-run efforts, mean sensor glucose across the fourteen-day wear sitting at 98 mg/dL against the reference range of 70 to 140 mg/dL for the sensor's rated interval. His fasting glucose on the CMP his primary drew last month came back at 97 mg/dL, flagged in the lab report as "within reference" against the standard 70-99 mg/dL band. His hemoglobin A1c on the same panel came back at 5.6 percent, flagged in the lab report as "within reference" against the standard non-diabetic ceiling of 5.7 percent. Both markers cleared their respective thresholds. Both markers, read in isolation, produced the primary's read of "glucose metabolism unremarkable; recommend dietary review with sports RD." The referral landed on my calendar with that framing.

The primary's read is not wrong on the individual markers. The interpretation of the paired panel is incomplete. The pattern the athlete is presenting — a fasting glucose creeping toward the upper reference boundary, a hemoglobin A1c sitting one-tenth of a percentage point below the pre-diabetic threshold, and a CGM two-week wear showing mean sensor glucose in the upper-normal band with post-meal excursions consistent with reduced insulin sensitivity — is exactly the pattern the sports-nutrition metabolic-flexibility differential is designed to catch. It is not diabetes. It is not pre-diabetes on the pathology-driven criteria. It is the reduced-carbohydrate-tolerance signal that the endurance-athlete population develops at a rate the general-population reference ranges were not calibrated to catch, and that has direct implications for how the athlete's fueling plan should be structured, how his training-load intensity distribution should be programmed, and how the sports RD documents the read so the coach conversation about the periodization redesign lands on the right question.

This post is the paired fasting-glucose-plus-HbA1c interpretation guide for the sports RD working with non-diabetic athletes: what the two markers actually measure and why they read a different signal from a CGM, the athlete-specific interpretive thresholds that shift the ceiling below the standard non-diabetic reference band, the four intake presentations that should trigger the paired panel at the sports RD's intake regardless of what the primary care panel already ran, the differential that separates the endurance-athlete reduced-carbohydrate-tolerance pattern from early insulin resistance from the acute-training-response distortions that shift both markers transiently, the SOAP assessment structure that names the metabolic-flexibility differential explicitly so the follow-up conversation with the referring physician starts at the correct question rather than a repeat of the "not diabetic" read, and the paired dietary-plus-training-load intervention loop the sports RD holds across the reassessment cadence.

What the Two Markers Actually Measure and Why They Complement Each Other

Fasting glucose is a point-in-time measurement of blood glucose after an 8-to-12-hour fast. It reflects the balance between hepatic glucose output (gluconeogenesis and glycogenolysis in the overnight fasted state) and peripheral glucose uptake (primarily muscle and adipose tissue insulin-driven uptake) at the moment of the draw. It is sensitive to acute perturbations — a hard training session in the 24 hours before the draw, poor sleep the night before, a late high-carbohydrate meal that extended into the fasting window, stress cortisol from a bad morning — and any of those can push a normally low-normal fasting glucose reading into the upper-normal or borderline-elevated range on a single draw. A single fasting glucose reading is a snapshot, not a trend.

Hemoglobin A1c is the percentage of hemoglobin molecules in circulating red blood cells that have been non-enzymatically glycated by ambient glucose. Because the average red blood cell has a lifespan of approximately 120 days, and the glycation reaction is a slow steady-state process, HbA1c reflects the integrated exposure of hemoglobin to glucose across the preceding roughly 8 to 12 weeks, with the most recent 30 days contributing about half the signal. It is insensitive to the acute perturbations that shift fasting glucose. It is however sensitive to conditions that shift red-cell lifespan — anemia (particularly iron-deficiency anemia which shortens red-cell turnover), recent significant blood loss, hemolytic conditions, hemoglobinopathies — and in the athlete population the marker can read falsely low in the setting of the sports-anemia pattern where hemodilution and modestly shortened red-cell lifespan are common. The A1c-to-average-glucose conversion also has known population-level variability; the standard conversion equation (average glucose in mg/dL = 28.7 × A1c − 46.7) reads a 5.6 percent A1c as an average glucose of roughly 114 mg/dL, but individual variation in that mapping is meaningful and the correlation is not perfect.

CGM measures interstitial glucose (not blood glucose directly) continuously across a 10-to-14-day wear window with a 1-to-5-minute sampling interval depending on the sensor. It captures the diurnal variation, the post-meal excursions, the exercise-induced drops, and the nocturnal patterns that neither fasting glucose nor A1c can see. It does not, however, replace the two lab markers. CGM produces a mean sensor glucose value across the wear that is often used as a proxy for average glucose, but the sensor's interstitial reading lags blood glucose by 5 to 15 minutes, the sensor's accuracy on the tails of the distribution (below 70 and above 180 mg/dL) is meaningfully lower than in the middle of the range, and the two-week wear window is a short integration compared to the 8-to-12-week window A1c captures.

The three markers read complementary signals: fasting glucose reads a snapshot of hepatic-versus-peripheral balance in the fasted state, A1c reads the integrated 8-to-12-week glucose exposure, and CGM reads the two-week detailed diurnal and post-meal pattern. Any two of the three can be misread in isolation. All three together triangulate the interpretation the primary panel misses.

The Athlete-Specific Interpretive Thresholds

The standard non-diabetic reference range for fasting glucose is 70 to 99 mg/dL. The pre-diabetic band starts at 100 mg/dL. The diabetes threshold is 126 mg/dL on two separate readings. The standard non-diabetic reference for HbA1c is below 5.7 percent. The pre-diabetic band is 5.7 to 6.4 percent. The diabetes threshold is 6.5 percent or higher.

Those thresholds were established on a general-adult population and were designed to catch the pathology-driven metabolic dysfunction that predicts cardiovascular disease and diabetes progression. They are appropriate for their intended purpose. For the sports RD's purpose — catching the reduced-carbohydrate-tolerance signal in an athlete presenting with performance stalling, weight-loss stall during a controlled deficit, or blunted training response — the interpretive ceiling should sit lower than the pathology-based thresholds. The functional target the sports-nutrition and sports-endocrinology literature has increasingly converged on: fasting glucose consistently below 95 mg/dL and HbA1c consistently below 5.4 percent in a metabolically-flexible endurance athlete. Athletes drifting into the 95-to-100 mg/dL fasting glucose band or the 5.4-to-5.7 percent A1c band are showing the reduced-carbohydrate-tolerance signal well before they will trigger the standard reference-range flag.

Two caveats on this athlete-specific ceiling. First, the sports-anemia pattern in some endurance athletes can push A1c artificially lower than the true integrated glucose exposure, so a marginally low A1c in the setting of a low-normal or low ferritin should be read cautiously — the A1c reading of 5.2 percent in an athlete with a ferritin of 22 may be reading the shortened red-cell lifespan rather than the actual glucose control. Second, individual variability in the A1c-to-average-glucose mapping means a single athlete's A1c interpretation should ideally be calibrated against paired CGM data at least once, rather than relying on the population conversion equation blindly.

The Four Intake Signals That Should Trigger the Paired Panel

The paired fasting-glucose-plus-HbA1c panel is not typically the first thing the primary care office runs when an athlete presents with performance-related complaints. The sports RD is often the professional who catches the pattern that warrants the panel and communicates the specific request back to the ordering provider. The four highest-yield intake triggers:

Performance stalling in a well-programmed training block with no other identifiable cause. The athlete whose training log documents good periodization, whose fueling log documents adequate energy intake, whose sleep and stress patterns are stable, and who nevertheless is not responding to the training with the expected adaptations. Reduced carbohydrate tolerance is one of the most under-recognized drivers of this presentation, and the paired panel is a low-cost high-yield workup for it.

Weight-loss stall during a controlled and adequately-programmed caloric deficit. The athlete who has been in a documented and reasonable deficit (300 to 500 kcal/day) for six to twelve weeks without the expected weight loss, and whose training and sleep pattern have not changed. Reduced insulin sensitivity blunts fat oxidation in the deficit state and produces exactly this pattern.

Blunted metabolic-conditioning response. The athlete whose interval sessions, tempo runs, or metabolic conditioning work feel harder than they should for the given wattage or pace, particularly with a subjective "flat" quality that shows up in the second half of the session. The reduced-carbohydrate-tolerance pattern impairs the glycolytic fueling of moderate-to-high-intensity work.

Family history of type 2 diabetes plus any of the above. Genetic predisposition to reduced insulin sensitivity means the athlete progresses through the reduced-carbohydrate-tolerance band faster than a comparably-trained peer without the family history, and the paired panel should be drawn at the sports RD intake regardless of the presenting complaint pattern in this population.

The Differential the Sports RD Holds

Reduced-carbohydrate-tolerance pattern (the endurance-athlete presentation). Fasting glucose 95 to 100 mg/dL, A1c 5.4 to 5.7 percent, CGM mean sensor glucose 95 to 110 mg/dL with post-meal excursions to 140 to 160 mg/dL on carbohydrate-dense meals returning to baseline over 90 to 120 minutes rather than the 60 to 90 minutes a metabolically-flexible athlete produces. The driver is a combination of chronically-elevated cortisol from training-plus-life stress, chronic high-carbohydrate dietary pattern without adequate intensity-distributed training to preserve insulin sensitivity, and the age-related decline in insulin sensitivity that starts in the mid-thirties. The intervention is dietary-pattern change (reduce refined carbohydrate, restructure carbohydrate timing around training windows, increase protein and vegetables) plus training-load intensity-distribution audit (many endurance athletes drift into the middle-intensity gray zone that blunts insulin sensitivity without producing the fitness gains of proper high-intensity work) plus resistance training if not already programmed.

Early insulin resistance or pre-diabetic pattern. Fasting glucose 100 to 125 mg/dL, A1c 5.7 to 6.4 percent, CGM mean sensor glucose over 110 mg/dL with post-meal excursions above 160 mg/dL and prolonged recovery times. This crosses into the primary-care and endocrinology treatment surface and warrants a referral for expanded workup (HOMA-IR calculation from paired fasting insulin, consideration of oral glucose tolerance test, cardiovascular risk-factor evaluation). The sports RD contribution remains the dietary and training-load intervention alongside whatever the primary or endo decides.

Acute training-response distortion. Fasting glucose elevated on a single draw following a hard training session in the last 24 to 48 hours, with A1c and CGM in the normal-athlete range. This is a false-positive on the single fasting glucose reading and should be repeated in a rested-state context before triggering any workup. Draw discipline (fasted state, no hard training in the prior 48 hours, morning draw before that day's training, adequate sleep the night before) is important on the fasting glucose interpretation.

Sports-anemia-driven A1c distortion. A1c reading in the low-normal or low band (below 4.8 percent) in an athlete with a low or low-normal ferritin and a hemoglobin trending toward the low end of reference. The A1c is reading the shortened red-cell lifespan rather than the actual glucose control, and the interpretation should defer to the paired fasting glucose and CGM rather than the artificially depressed A1c.

The SOAP Documentation

The assessment line names the differential so the referring physician conversation starts at the correct question. My structure on the reduced-carbohydrate-tolerance pattern: "Reduced carbohydrate tolerance differential holds. Paired panel [date] showed fasting glucose [value] mg/dL against the standard reference ceiling of 99 mg/dL and the athlete-population functional ceiling of 95 mg/dL, HbA1c [value] percent against the standard non-diabetic ceiling of 5.7 percent and the athlete-population functional ceiling of 5.4 percent. Paired CGM 14-day wear [date range] showed mean sensor glucose [value] mg/dL with post-meal excursions to [peak value] mg/dL on carbohydrate-dense meals with recovery time [minutes] against the metabolically-flexible-athlete target of 60 to 90 minutes. Neither marker crosses the pre-diabetic or diabetic thresholds and the presentation is not a primary-care or endocrinology treatment question. Presenting pattern of performance-stall / weight-loss-stall / blunted-metabolic-conditioning-response in the setting of [training-load context] combined with the paired-panel findings is consistent with the endurance-athlete reduced-carbohydrate-tolerance pattern documented in the sports-endocrinology literature. Intervention plan documented below. Reassessment at 10 to 12 weeks with paired-panel redraw plus follow-up CGM 14-day wear."

The plan documents five elements: dietary-pattern intervention (reduce refined carbohydrate and added sugar aggressively, restructure the remaining carbohydrate around training windows with a lower-carbohydrate default at rest and pre-loaded carbohydrate around key sessions, increase protein intake to 1.8 to 2.2 g/kg with adequate distribution across meals, increase non-starchy vegetable intake, reduce alcohol); training-load intensity-distribution audit with the coach (the polarized-training vs pyramidal-training vs gray-zone conversation, with the specific recommendation to reduce the middle-intensity gray-zone volume and reallocate to high-intensity threshold-and-VO2max work if that work is under-represented in the current program); resistance training programming if not currently in the plan (2 to 3 sessions per week of compound movements at progressive load); sleep-quality intervention protocol; and reassessment cadence — paired-panel redraw at 10 to 12 weeks, follow-up CGM 14-day wear at the same window, subjective-and-objective training-response check at 4-week interim.

The Reassessment Loop

Paired-panel redraw at 10 to 12 weeks reads three outcomes:

Fasting glucose consistently below 95 mg/dL, A1c consistently below 5.4 percent, CGM excursions and recovery times normalized, presenting complaint resolved. The reduced-carbohydrate-tolerance pattern was the driver, the intervention landed, continue the intervention through the training block, and use the paired panel proactively at annual macrocycle checkpoints as a monitoring tool.

Both markers partially improved, CGM improved, subjective complaint partially improved. Intensification of the intervention — reduce refined carbohydrate further, tighten training-load intensity-distribution discipline, add resistance-training volume, extend the reassessment window by another 8 to 12 weeks. Reassess the intervention specifics rather than declaring the differential wrong.

Both markers unchanged or worsened, CGM unchanged, subjective complaint unchanged. The differential expands. Referral back to the sports-medicine physician for the HOMA-IR calculation and consideration of endocrinology consult if the pattern has crossed into the pre-diabetic thresholds on the redraw. Consider the coexisting-metabolic-dysfunction workup (thyroid, testosterone, cortisol) if the pattern is unexplained by the intervention-response.

Why This Panel Should Be on the Sports RD Intake Checklist for the Right Presentations

The paired fasting-glucose-plus-HbA1c panel is inexpensive (frequently covered by insurance when ordered with a sports-medicine referral, or $15 to $30 direct-to-consumer), fast to draw, and highly interpretable in the sports RD's hands when the athlete-specific thresholds are held rather than the standard reference-range thresholds. It complements CGM rather than duplicating it, and it catches the presentation that CGM alone can miss because the two-week CGM wear does not integrate the 8-to-12-week signal the A1c captures.

The panel does not replace the sports RD's clinical judgment about dietary-pattern change and training-load intensity distribution. It gives the sports RD an empirical foundation for the intervention plan and gives the athlete an objective baseline against which to measure the response. The athletes I have seen respond most cleanly to the intervention are the ones who could see the fasting glucose come down from 98 to 88 mg/dL and the A1c come down from 5.6 to 5.2 percent across the reassessment window, and could correlate that with the return of the training response they had been chasing. The numbers are the anchor that makes the dietary-pattern discipline sustainable across the intervention window.

Where Calsanova Fits

The paired-panel workup depends on the intake holding the CGM data alongside the labs, on the paired computation of the athlete-specific functional-threshold flags rather than the standard reference-range flags, on the training-load intensity-distribution audit surfaced in the same session as the panel review, and on the reassessment schedule tracked automatically against the intervention start date. Calsanova's clinical intake carries the paired glucose-plus-A1c-plus-CGM entry with automatic athlete-specific threshold flagging (95 mg/dL fasting glucose and 5.4 percent A1c as the sports-nutrition functional ceilings, distinct from the standard reference flags), the paired CGM wear-integration that surfaces the mean sensor glucose plus post-meal excursion pattern plus recovery-time computation, the intensity-distribution audit prompt that pairs the panel review with the training-load conversation, and the pre-scaffolded referring-physician communication template that names the reduced-carbohydrate-tolerance differential explicitly so the follow-up conversation starts at the correct question. The reassessment schedule pre-populates the 10-to-12-week paired-panel and CGM-wear redraw with the interim 4-week symptom-and-training-response check, and the intervention-response tracker flags the trajectory of both markers plus the CGM pattern across the reassessment window.

Ready to move your sports-nutrition intake workflow into a purpose-built clinical system? Try Calsanova free for 30 days — no credit card, HIPAA-ready from day one, and the paired fasting-glucose-plus-HbA1c workup runs automatically with the athlete-specific thresholds and CGM integration built in, and the reassessment schedule pre-populates against the intervention start date.